WST · 8-K · 20261029PR000118

Income Tax Rate Changes

WEST PHARMACEUTICAL SERVICES INC · 2026-10-29 · Importance 65 · Surprise 82

Third-quarter income tax expense rose to $58.0 million from $34.0 million, while pretax income increased to $267.7 million from $171.9 million. The reported effective tax rate was approximately 21.7% in the quarter, versus 19.8% a year earlier. West also recorded a one-time $22.4 million tax cost associated with the SmartDose® asset-sale gain and a $12.0 million tax cost from an internal legal-entity restructuring in the first quarter of 2026.

Key facts